Novartis is stepping on the cGAS. Three years after securing an option on an IFM Therapeutics subsidiary, the Swiss drugmaker has accelerated into the deal and paid $90 million upfront for small ...

IFM Investors has sold a majority stake in an Australian mall to Vicinity Centres for A$212m (€127m). Vicinity, which already owns 25% of the Uptown mall, located in Brisbane, intends to acquire ...

DigitalBridge & IFM Investors have completed the $11 billion acquisition of data center firm Switch Inc. The deal was first announced in May 2022. With the closing of the deal, Switch has been taken ...

IFM Investors Pty is in talks to raise about 1.6 billion Swiss francs ($2 billion) in debt to back its acquisition of Swiss data center operator Green Group AG, people with knowledge of the matter ...

Private credit market involves non-bank lenders, like private funds and asset managers, providing direct loans to companies. Read more at straitstimes.com. Read more at straitstimes.com.

Just five months after Novartis put down $310 million for IFM Therapeutics’ inflammation-focused unit, the Big Pharma has come back for more. This time, it is teaming up with IFM Due, the subsidiary ...

HOUSTON--(BUSINESS WIRE)--IFM Investors (“IFM”) today announced the formation of Mobius Renewables (the “Company”), a new global, vertically integrated low carbon fuels platform established to ...

London | IFM Investors, the asset management giant owned by Australia’s largest superannuation funds, is facing an increasingly hostile reception in Spain amid a boardroom brawl at gas and electricity ...

Australian investment manager IFM Investors will wind down its domestic private equity unit in coming years, citing a lack of scale to make it commercially viable and a focus on other global ...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall ...

IFM Investors’ dealmakers are back to punch their ticket at the $7.65 billion toll roads operator Atlas Arteria, as their six-month creep provisions roll in. Atlas Arteria CEO Hugh Wehby. Eamon ...